Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

422 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Tumor vasculature targeting through NGR peptide-based drug delivery systems.
Corti A, Curnis F. Corti A, et al. Curr Pharm Biotechnol. 2011 Aug;12(8):1128-34. doi: 10.2174/138920111796117373. Curr Pharm Biotechnol. 2011. PMID: 21470145 Review.
Tumor targeting with biotinylated tumor necrosis factor alpha: structure-activity relationships and mechanism of action on avidin pretargeted tumor cells.
Corti A, Gasparri A, Sacchi A, Curnis F, Sangregorio R, Colombo B, Siccardi AG, Magni F. Corti A, et al. Cancer Res. 1998 Sep 1;58(17):3866-72. Cancer Res. 1998. PMID: 9731496
Tumour necrosis factor: strategies for improving the therapeutic index.
Corti A, Marcucci F. Corti A, et al. J Drug Target. 1998;5(6):403-13. doi: 10.3109/10611869808997869. J Drug Target. 1998. PMID: 9783674 Review.
Induction of therapeutic T-cell immunity by tumor targeting with soluble recombinant B7-immunoglobulin costimulatory molecules.
Moro M, Gasparri AM, Pagano S, Bellone M, Tornaghi P, Veglia F, Corti A, Casorati G, Dellabona P. Moro M, et al. Among authors: corti a. Cancer Res. 1999 Jun 1;59(11):2650-6. Cancer Res. 1999. PMID: 10363988
Tumor pretargeting with avidin improves the therapeutic index of biotinylated tumor necrosis factor alpha in mouse models.
Gasparri A, Moro M, Curnis F, Sacchi A, Pagano S, Veglia F, Casorati G, Siccardi AG, Dellabona P, Corti A. Gasparri A, et al. Among authors: corti a. Cancer Res. 1999 Jun 15;59(12):2917-23. Cancer Res. 1999. PMID: 10383155
Enhancement of tumor necrosis factor alpha antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13).
Curnis F, Sacchi A, Borgna L, Magni F, Gasparri A, Corti A. Curnis F, et al. Among authors: corti a. Nat Biotechnol. 2000 Nov;18(11):1185-90. doi: 10.1038/81183. Nat Biotechnol. 2000. PMID: 11062439
Roles of tumor necrosis factor p55 and p75 receptors in TNF-alpha-induced vascular permeability.
Ferrero E, Zocchi MR, Magni E, Panzeri MC, Curnis F, Rugarli C, Ferrero ME, Corti A. Ferrero E, et al. Among authors: corti a. Am J Physiol Cell Physiol. 2001 Oct;281(4):C1173-9. doi: 10.1152/ajpcell.2001.281.4.C1173. Am J Physiol Cell Physiol. 2001. PMID: 11546653
Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells.
Curnis F, Arrigoni G, Sacchi A, Fischetti L, Arap W, Pasqualini R, Corti A. Curnis F, et al. Among authors: corti a. Cancer Res. 2002 Feb 1;62(3):867-74. Cancer Res. 2002. PMID: 11830545
Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration.
Curnis F, Sacchi A, Corti A. Curnis F, et al. Among authors: corti a. J Clin Invest. 2002 Aug;110(4):475-82. doi: 10.1172/JCI15223. J Clin Invest. 2002. PMID: 12189241 Free PMC article.
Characterisation of functional biotinylated TNF-alpha targeted to the membrane of apoptotic melanoma cells.
Zimmermann VS, Bondanza A, Rovere-Querini P, Colombo B, Sacchi A, Fascio U, Corti A, Manfredi AA. Zimmermann VS, et al. Among authors: corti a. J Immunol Methods. 2003 May 1;276(1-2):79-87. doi: 10.1016/s0022-1759(03)00069-3. J Immunol Methods. 2003. PMID: 12738361
422 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback